🇺🇸 FDA
Pipeline program

VHX-896 and iloperidone

VP-VHX-896-1103

Phase 1 small_molecule completed

Quick answer

VHX-896 and iloperidone for Schizophrenia is a Phase 1 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Vanda Pharmaceuticals
Indication
Schizophrenia
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials